University of Notre Dame du Lac’s Heron Therapeutics HRTX Stock Holding History

University of Notre Dame du Lac’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-52,288	Closed	-$614K	–	44
2020 Q1	$614K	Buy	52,288 +6,428	+14%	+$121K	0.19%	54
2019 Q4	$1.08M	Sell	45,860 -6,817	-13%	-$151K	0.34%	40
2019 Q3	$975K	Sell	52,677 -150,016	-74%	-$2.76M	0.29%	40
2019 Q2	$3.77M	Sell	202,693 -210,012	-51%	-$4.2M	0.85%	47
2019 Q1	$10.1M	Buy	412,705 +316,969	+331%	+$8.3M	2.25%	9
2018 Q4	$2.48M	Sell	95,736 -44,630	-32%	-$1.23M	0.6%	49
2018 Q3	$4.44M	Buy	140,366 +53,650	+62%	+$2M	0.83%	43
2018 Q2	$3.37M	Buy	+86,716	New	+$2.76M	0.65%	47

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

University of Notre Dame du Lac's HRTX Position: Q2 2020 in Review

University of Notre Dame du Lac sold out of Heron Therapeutics (HRTX) in Q2 2020, closing a stake of 52,288 shares — an estimated $614K sold.

University of Notre Dame du Lac first reported a position in HRTX in Q2 2018 and held it in 8 quarters. The position peaked at $10.1M in Q1 2019. 190 funds tracked by Wall St. Rank hold HRTX as of Q2 2020.

University of Notre Dame du Lac reported no remaining Heron Therapeutics position as of Q2 2020 after selling out during the quarter.
University of Notre Dame du Lac sold 52,288 Heron Therapeutics shares in Q2 2020, an estimated $614K.
University of Notre Dame du Lac first reported a position in Heron Therapeutics in Q2 2018 and held it in 8 quarters.
University of Notre Dame du Lac's Heron Therapeutics position peaked at $10.1M in Q1 2019.
190 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2020.

Based on University of Notre Dame du Lac's 13F filing for Q2 2020, filed 14 Aug 2020.